A complete 2026 implementation guide: approved indications, staff training, patient scheduling, contraindications, and the financial case — from 60+ Israeli clinics.
May 2026 · 8 min read · Clinic Integration
PEMF's mechanism — cellular-level anti-inflammation, tissue repair, pain signal modulation — is a direct complement to what physiotherapy already does. Where physio addresses movement dysfunction and structural alignment, PEMF addresses the underlying cellular environment. The combination consistently produces better outcomes than either alone.
Over 60 physiotherapy, osteopathy, and rehabilitation clinics in Israel have integrated PainFree PEMF systems. The average clinic sees full operational integration within 2–4 weeks.
PEMF uses low-frequency (1–100 Hz) pulsed electromagnetic fields to trigger four key cellular mechanisms:
These mechanisms address the root cause of chronic pain, not just symptom suppression.
A 2025 multicenter randomized controlled trial (PMC11914662, n=91) demonstrated 36% pain reduction versus 10% in standard care (p<0.0001), and 55% medication reduction versus 12% in the control group. A Cochrane review (CD003523.pub2, 9 studies, 636 participants) found approximately 15-point pain reduction on a 0–100 scale versus placebo. Trock 1993 (n=25) showed 23–61% improvement in knee OA with PEMF versus 2–18% in the placebo group.
| Parameter | PEMF | Ultrasound | TENS |
|---|---|---|---|
| Pain reduction (RCT data) | 36% | 15–20% | ~20% |
| Treatment contact | No contact, through clothing | Requires gel/transducer | Skin electrodes |
| Supervision required | No | Yes | Recommended |
| Indication range | Wide and systemic | Shallow musculoskeletal | Symptomatic only |
| Throughput per device | Multiple simultaneous patients | 1:1 only | 1:1 typically |
At Philippine private clinic rates: a 10-session PEMF treatment series at ₱1,500–₱2,500 per session generates ₱15,000–₱25,000 per patient. A single device running 4 patients per hour generates ₱6,000–₱10,000 per hour — with zero therapist time during treatment. Monthly revenue from a single device easily covers operational costs within the first few months.
Absolute: Active pacemaker or defibrillator, pregnancy, active epilepsy, active malignancy in treatment area.
Relative: Metal implants near treatment site, thyroid dysfunction, active local infection.
Request the full investor package.
Request Investment Brief →